Keywords: ACE; Acetaminophen; AMTP; amitriptyline; AML; amlodipine; ARI; aripiprazole; BEN; benzoylecgonine; BUP; buprenorphine; CAF; caffeine; CBZ; carbamazepine; DES-Me-SER; desmethylsertraline; DCF; diclofenac; DLZ; diltiazem; DIP; diphenhydramine; DUL; duloxeti
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CSC; cancer stem cells; EMT; epithelial to mesenchymal transition; MET; mesenchymal to epithelial transition; AML; acute myeloid leukemia; ALDH1; aldehyde dehydrogenase 1; BCSC; breast cancer stem cell; Lgr5; G-protein-coupled receptor 5; GSC; glioblastom
Keywords: TSC; tuberous sclerosis; CT; computerized tomographic; EEG; electroencephalogram; mTOR; the mammalian target of rapamycin; IS; infantile spasms; AEDs; anti epilepsy drugs; VGB; vigabatrin; SEGA; subependymal giantcell astrocytoma; AML; angiomyolipoma; ILA
Keywords: ALL; acute lymphoblastic leukaemia; AML; acute myeloid leukaemia; APL; acute promyelocytic leukaemia; ASR; age standardised incidence rates; CI; confidence interval; CML; chronic myeloid leukaemia; ECP; Eastern Cape Province; HMs; haematological malignanc
Keywords: thrombosis; peripherally inserted central catheters; central venous line; infant leukemia; ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; CAT; Catheter-associated thrombosis; CVL; Central venous line; L-ASP; L-asparaginase; LMWH; Low-mole
Keywords: Acute promyelocytic leukemia; AML; AYA; HSCT; Low- to middle-income countries;
Keywords: Myeloproliferative neoplasm; MPN; Blast phase; Leukemic transformation; Acute myeloid leukemia; AML;
Keywords: ALL; acute lymphoid leukemia; AML; acute myeloid leukemia; CLL; chronic lymphoid leukemia; CML; chronic myeloid leukemia; Hb; hemoglobin; WBC; white blood cell;
Keywords: Hematopoietic stem cell transplantation; Taste changes; Biographical disruption; Qualitative research; HSCT; Haematopoietic stem cell transplantation; TBI; Total body irradiation; AML; Acute myeloid leukaemia; CML; Chronic myeloid leukaemia; ALL; Acute ly
Keywords: ALL; acute lymphoid leukaemia; AML; acute myeloid leukaemia; RETI-SEHOP; Spanish Registry of Childhood Tumours; FC; Navteq cartography Functional Class; ORs; odds ratios; 95%CIs; 95% confidence intervals; IARC; International Agency for Research on Cancer;
Keywords: Ara-C; cytarabine; LA; lauric acid; LA-Ara; conjugation of cytarabine with lauric acid; LA-Ara NFs; LA-Ara nanofibers; AML; acute myeloid leukaemia; ALL; acute lymphoblastic leukaemia; lg P; oil/water partition coefficient; Ara-CTP; cytarbine triphosphate
Keywords: VTE; venous thromboembolism; HSCT; hematopoietic stem cell transplant; LMWH; low molecular weight heparin; IMIDs; immunomodulatory drugs; AML; acute myeloid leukemia; IQR; interquartile range; TAT; thrombin antithrombin; FVII; factor VII; FVIII; factor VI
Keywords: 5-Aza; 5-Aza-2-deoxycytidine; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; BIR; baculoviral inhibitor of apoptosis repeat; CAD; caspase-activated deoxyribonuclease; CDK; cyclin-dependent kinase; cIAP; cellular inhibitor of apoptosis; CL
Keywords: EV; extracellular vesicles; ILVs; intraluminal vesicles; BMSCs; bone marrow stromal cells; AML; acute myeloid leukemia; CML; chronic myelogenous leukemia; CLL; chronic lymphocytic leukemia; ALL; acute lymphoblastic leukemia; EGF; epidermal growth factor;
Keywords: AML; acute myeloid leukemia; CH; clonal hematopoiesis; CHIP; clonal hematopoiesis of indeterminate potential; FDA; Food and Drug Administration; MDS; myelodysplastic syndrome; MGUS; monoclonal gammopathy of undetermined significance; MRD; minimal residual
Keywords: AML; HMA; Hypomethylating agent; Myelosysplastic syndrome;
Keywords: 7â+â3; cytarabine 7 days and daunorubicin (3 days); AE; adverse event; alloHSCT; allogeneic hematopoietic stem cell transplant; AML; acute myeloid leukemia; AML-MRC; AML with myelodysplasia-related changes; AR; allelic ratio; BSC; best supportive care
Keywords: ACE; acetaminophen; AMI; amitriptyline; ARI; aripiprazole; BEN; benzoylecgonine; BUP; buprenorphine; CAF; caffeine; CAR; carbamazepine; DIC; diclofenac; DIL; diltiazem; DIP; diphenhydramine; DUL; duloxetine; FLU; fluoxetine; MPH; methylphenidate; NOR; nor
Keywords: Axial piston pump; Flexible multi-body dynamics; Noise reduction; AML; Noise transmission path; Optimisation;
Keywords: Hospital dentistry; cancer; gingiva; Abx; Antibiotics; AL; Acute leukemia; ALL; B- and T-lymphoblastic leukemia or lymphoma; AL NOS; Acute leukemia (not otherwise specified); AML; Acute myeloid leukemia; GE; Gingival enlargement; GH; Gingival and periodon
Keywords: Aml; amlodipine; Ca2+; free calcium; DHP; dihydropyridine; Dil; diltiazem; Epo; erythropoietin; EpoR; erythropoietin receptor; FBS; fetal bovine serum; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; PBS; phosphate-buffered saline; Pyr3; TRPC3 inhibitor;
Keywords: AML; Acute myeloid leukemia; BBB; blood-brain barrier; BCAAs; branched-chain amino acids; ecDNA; extrachromosomal DNA; FH; fumarate hydratase; GBM; glioblastoma multiforme; HIF1/2; hypoxia-inducible factor 1/2; IDH1/2; isocitrate dehydrogenases 1/2; LXR;
Keywords: 8D; Eight Disciplines; AML; Aras Markup Language; CBR; Case-Based Reasoning; CIP; Continuous Improvement Process; ECR; Engineering Change Request; GUI; Graphical User Interface; ID; IDdentification number; KM; Knowledge Management; LLS; Lessons Learned Sy
Keywords: AML; acute myeloid leukemia; DFS; disease-free survival; DLBCL; diffuse large B-cell lymphoma; DSPC; 1,2-distearoyl-sn-glycero-3-phosphocholine; DSPE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine; EPR; enhanced permeation and retention; MB; molecular b
Keywords: NF; Number of fires; BA; Burnt area; TNF; Total number of fires; TBA; Total burnt area; CLC; CORINE Land Cover 2006; NUTS; Nomenclature of Territorial Units for Statistics; AML; Área Metropolitana de Lisboa; h; Altitude; DEM; Digital elevation model; s;
Keywords: Primary immunodeficiency; Hematologic malignancy; Lymphoma; Leukemia; Hodgkin; AD; Autosomal dominant; ADA; Adenosine deaminase; AML; Acute myeloid leukemia; AR; Autosomal recessive; CID; combined immunodeficiency; HL; Hodgkin lymphoma; HLH; Hemophagocyti
Keywords: ACH; Air Changes per Hour; AML; Algebraic Modelling Language; AMY; Actual Meteorological Year; AR; Autoregressive; ARIMA; Autoregressive Integrated Moving Average; ARMA; Autoregressive Moving Average; ARMA-GARCH; Autoregressive Moving Average - Generali
Keywords: FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: ARV-825 PubChem CID 92044400; BETd-246 PubChem CID 131698640; dBET1 PubChem CID 91799313; I-BET151 PubChem CID 52912189; I-BET762 PubChem CID 46943432; JQ1 PubChem CID 46907787; MS417 PubChem CID 59190723; OTX015 PubChem CID 9936746; THZ1 PubChem CID 7360
Keywords: Acute myeloid leukemia; AML; Response criteria; Minimal residual disease; MRD; Clinical trials;
Keywords: Cladribine; Cytarabine; Idarubicin; Acute myeloid leukemia; Induction chemotherapy; Leukemia risk; NCCN; ELN; Anthracycline; Risk prediction; Prognosis; AML;
Keywords: AML; Minimal residual disease; Risk stratification; Stem cell transplantation;
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: Mass cytometry; AML; Microenvironment; Immunotherapy;
Keywords: Eosinophilic; Solid; Cystic; RCC; Mimicking; Epithelioid; AML;
Keywords: 2-dimensional echocardiography; 3-dimensional echocardiography; computed tomography; direct transcatheter annuloplasty; indirect transcatheter annuloplasty; mitral regurgitation; mitral stenosis; paravalvular mitral leak; transcatheter mitral intervention
Keywords: AML; acute myeloid leukemia; BSC; best supportive care; CI; confidence interval; CIR; cumulative incidence of relapse; CR; complete remission; CRc; composite CR (includes CR, CRi, and CRp); CRi; CR with incomplete hematologic recovery; CRMRDâ; CR with a
Keywords: 5mC; 5- hydroxymethylcytosine; AML; acute myeloid leukemia; BET; bromodomain inhibitors; CCOC; clear cell ovarian cancer; ctDNA; cell-free tumor DNA; ChIP-on-chip; chromatin immunoprecipitation with DNA microarray; CIMP; CpG island methylator phenotype; C
Keywords: BTK; Bruton tyrosine kinase; PTK2; protein tyrosine kinase 2; TSPAN7; tetraspanin 7; CTSD; cathepsin; MEF2C; myocyte enhancer factor 2C; TCF3; transcription factor 3; FES; Feline sarcoma; RPL36A; ribosomal protein L36a; NCF4; neutrophil cytosolic factor 4
Keywords: Treosulfan; Total body irradiation; Allogeneic hematopoietic cell transplantation; AML; MDS;
Keywords: AML; acute myeloid leukemia; ChIP; Chromatin immunoprecipitation; CML; chronic myeloid leukemia; ECM; extracellular matrix; GO; gene ontology; CD29/ITGB1; integrin beta 1; HIP1; huntingtin interacting protein; DAB2; disabled homolog 2; SDC1; syndecan 1; L
Keywords: LC-MS; Liquid Chromatography Mass Spectrometry; CD; circular dichroism; ESR; Electron Spin Resonance; SPR; Surface Plasmon Resonance; CTD; C-terminal domain; NPM1; Nucleophosmin; LUV; Large Unilamellar Vesicle; AML; acute myeloid leukemia; HFIP; (1,1,1,
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; CatK; cathepsin K; CXCR4; C-X-C receptor type 4; DLL4; Delta-like ligand 4; GSC; glioma stem cell; EC; endothelial cell; ECM; extracellular matrix; GM-CSF; granulocyte/macrophage colony-stimu
Keywords: 5-FU; 5-Fluorouracil; ABCB5; ATP-binding cassette sub-family B member 5; ABCC2; ATP-binding cassette sub-family C member 2; ABCG2; ATP-binding cassette sub-family G member 2; ACs; Anthocyanins; ALDH; aldehyde dehydrogenase; AML; acute myeloid leukemia; AP
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; CLL; B-cell chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; ERK; extracellular signal-regulated kinase; FN3; fibronectin type-III (domain); GBM; glioblastoma multiforme; JMML
Keywords: AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ADAM; a disintegrin and metalloproteinase enzymes; ALDH; aldehyde dehydrogenase; ABC; ATP - binding cassette; BWS; Beckwith-Wiedemann syndrome; BMP; bone morphogenetic proteins; CSC; cancer s
Keywords: PLK4; Polo-like kinase 4; FACS; fluorescence activated cell sorting; DMSO; dimethylsulfoxide; AML; acute myeloid leukemia; T-ALL; T-cell acute lymphoblastic leukemia; ABL1; Abelson Tyrosine-Protein Kinase 1; LRRK2; Leucine Rich Repeat Kinase 2; BRD4; Brom
Keywords: AML; Decision making; Geriatric; MDS; QOL;
Keywords: AML; Day 14; Bone marrow biopsy; Complete remission; Prognostic factors;
Keywords: γc; common gamma chain, CD132; IL; interleukin; sγc; soluble form of common gamma chain; JAK; Janus-activated kinase; STAT; signal transducer and activator of transcription; T-ALL; T-cell acute lymphocytic leukemia; B-ALL; B-cell acute lymphocytic leuke